View:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(AMENDMENT NO. 1)*
TELA Bio, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
872381108
(CUSIP Number)
December 31, 2021
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ X ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
CUSIP No.
872381108
13G
Page 2 of 7 Pages
1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Pura Vida Investments, LLC
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) [ ]
(b) [ x ]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
564,120*
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
564,120*
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
564,120*
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [ ]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.89%**
12.
TYPE OF REPORTING PERSON (see instructions)
IA
CUSIP No. 872381108
13G
Page 3 of 7 Pages
1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Efrem Kamen
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) [ ]
(b) [ x ]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
564,120*
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
564,120*
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
564,120*
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [ ]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.89%**
12.
TYPE OF REPORTING PERSON (see instructions)
IN, HC
CUSIP No. 872381108
13G
Page 4 of 7 Pages
Item 1.
(a)
Name of Issuer
TELA Bio, Inc.
(b)
Address of Issuer's Principal Executive Offices
1 Great Valley Parkway, Suite 24 Malvern PA 19355
Item 2.
(a)
Name of Person Filing
Pura Vida Investments, LLC
Efrem Kamen, (collectively, the "Filers").
(b)
The address of the principal place of the Filers is located at:
Pura Vida Investments, LLC 888 7th Avenue 6th Floor New York, New York 10106
(c)
For citizenship of Filers, see Item 4 of the cover sheet for each Filer.
(d)
Title of Class of Securities
Common Stock
(e)
CUSIP Number
872381108
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
(a)
[ ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)
[ ]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)
[ ]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d)
[ ]
Investment company registered under section 8 of the Investment Company
Act of 1940 (15 U.S.C. 80a-8).
(e)
[x]
An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f)
[ ]
An employee benefit plan or endowment fund in accordance with
240.13d-1(b)(1)(ii)(F);
(g)
[ ]
A parent holding company or control person in accordance with
240.13d-1(b)(1)(ii)(G);
(h)
[ ]
A savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);
(i)
[ ]
A church plan that is excluded from the definition of an investment company
under section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3);
(j)
[ ]
Group, in accordance with 240.13d-1(b)(1)(ii)(J).
CUSIP No. 872381108
13G
Page 5 of 7 Pages
Item 4. Ownership.
(a) Amount beneficially owned: Pura Vida Investments LLC 564,120*
shares Efrem Kamen 564,120* shares.
(b) Percent of class: Pura Vida Investments LLC 3.89%**
Efrem Kamen 3.89%**
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote 0
(ii) Shared power to vote or to direct the vote Pura Vida Investments LLC
564,120*
shares Efrem Kamen 564,120* shares
(iii) Sole power to dispose or to direct the disposition of 0
(iv) Shared power to dispose or to direct the disposition of Pura Vida
Investments, LLC 564,120* shares Efrem Kamen 564,120* shares
*Shares reported herein are held by Pura Vida Master Fund, Ltd.
(the Pura Vida Master Fund), and certain separately managed accounts
(the Accounts). Pura Vida Investments, LLC (PVI) serves as the investment
manager to the Pura Vida Master Fund and the Accounts. Efrem Kamen serves
as the managing member of PVI. By virtue of these relationships, the Reporting
Persons may be deemed to have shared voting and dispositive power with respect
to the Shares owned directly by the Pura Vida Master Fund and the Accounts.
This report shall not be deemed an admission that the Reporting Persons are
beneficial owners of the Shares for purposes of Section 13 of the Securities
Exchange Act of 1934, as amended, or for any other purpose. Each of the
Reporting Persons disclaims beneficial ownership of the Shares reported herein
except to the extent of the Reporting Persons pecuniary interest therein.
** According to Company's 10-Q Quarterly Report for the Third Quarter ended
September 30, 2021 filed by the Company on or about November 12, 2021,
the number of shares of the Company's Common Stock outstanding
on December 31, 2021 was 14,503,570 shares.
Item 5. Ownership of Five Percent or Less of a Class.
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
CUSIP No. 872381108
13G
Page 6 of 7 Pages
N/A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any
transaction having that purpose or effect.
Exhibits. Exhibit A Joint Filing Agreement.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true,
complete and correct. Dated: February 14, 2022
Pura Vida Investments, LLC
By: /s/ Efrem Kamen, Managing Member
CUSIP No. 872381108
13G
Page 7 of 7 Pages
EXHIBIT A
AGREEMENT REGARDING JOINT FILING
OF STATEMENT ON SCHEDULE 13D OR 13G, The undersigned agree to file jointly
with the Securities and Exchange
Commission (the "SEC") any and all statements on Schedule 13D or Schedule 13G
(and any amendments or supplements thereto) required under section 13(d) of
the Securities Exchange Act of 1934, as amended, in connection with purchases
and sales by the undersigned of the securities of any issuer until such time
as the undersigned file with the SEC a statement terminating this
Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G.
For that purpose, the undersigned hereby constitute and appoint Pura
Vida Investment, LLC , a limited liability company, as their true and
lawful agent and attorney-in-fact, with full power and authority for and on
behalf of the undersigned to prepare or cause to be prepared, sign, file with
the SEC and furnish to any other person all certificates, instruments,
agreements and documents necessary to comply with section 13(d) and section
16(a) of the Securities Exchange Act of 1934, as amended, in connection
with said purchases and sales, and to do and perform every act necessary
and proper to be done incident to the exercise of the foregoing power, as
fully as the undersigned might or could do if personally present, until
such time as the undersigned file with the SEC a statement terminating
this Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G.
Dated: February 14, 2022
Pura Vida Investments, LLC
By: /s/ Efrem Kamen, Managing Member